Pharmacokinetic considerations in the treatment of bacterial keratitis.

Callegan, M C; O'Callaghan, R J; Hill, J M

Callegan, M C; O'Callaghan, R J; Hill, J M.

Affiliation

Callegan MC; Department of Microbiology, Louisiana State University Medical Center School of Medicine, New Orleans.

Clin Pharmacokinet ; 27(2): 129-49, 1994 Aug.

Article in En | MEDLINE | ID: mdl-7955776

Subject(s)

Eye Infections, Bacterial/drug therapy; Keratitis/drug therapy; Animals; Anti-Bacterial Agents/administration & dosage; Anti-Bacterial Agents/therapeutic use; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Collagen; Drug Carriers; Drug Resistance, Microbial; Eye Infections, Bacterial/microbiology; Humans; Iontophoresis; Keratitis/microbiology; Ophthalmic Solutions; Pseudomonas Infections/drug therapy; Staphylococcal Infections/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Eye Infections, Bacterial / Keratitis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Clin Pharmacokinet Year: 1994 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links